Firefly Neuroscience Is Acquiring Proprietary Brain Mapping Data

Firefly Neuroscience wants to be on the leading edge of brain health technology. Which is exactly why they’re making a new acquisition.

‍What’s happening:‍

• Firefly Neuroscience (NASDAQ: AIFF) has acquired Evoke Neuroscience for $6M USD
  

By the numbers:‍

• Firefly Neuroscience paid $3M USD in cash and $3M USD in equity as part of the acquisition
  

Why it matters:‍

• Evoke Neuroscience has developed proprietary technology that has been cleared by the United States Food and Drug Administration to help detect cognitive and mental disorders early through non-invasive brain assessments
  

Going deeper:‍

• Evoke Neuroscience has successfully completed more than 100,000 individual brain assessments
  
• The new acquisition of Evoke Neuroscience will triple Firefly Neuroscience’s patent portfolio and dramatically increase their commercial partners
  

The intrigue:‍

• Firefly Neuroscience previously made waves when they were accepted into Nvidia’s (NASDAQ: NVDA) Connect Program to accelerate the development of foundational artificial intelligence models for the human brain

‍